You are here

Home » Reports

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

Displaying 1 - 10 of 1186 results
 
  • Record 1 TO 1000
  • Record 1001 TO 1186

  1. ZONE I SOIL DECONTAMINATION THROUGH IN SITU VAPOR STRIPPING PROCESSES

    SBC: Aware, Inc.            Topic: N/A

    THE REMEDIATION OF CONTAMINATED SOILS AND GROUNDS TO ENSURE PROTECTION OF PUBLIC HEALTH AND THE ENVIRONMENT IS DIFFICULTAND COSTLY. THERE IS A CRITICAL NEED FOR THE DEVELOPMENT OFTECHNOLOGIES WHICH ARE BOTH TECHNICALLY SOUND AND COST- EFFECTIVE. THE POTENTIAL REMOVAL OF ROGANIC CHEMICALS FROM UNSATURATED SOILS VIA VAPOR PHASE TRANSPORT APPEARS TO SHOW GREAT PROMISE. THIS APPROACH HAS APPLICABILITY ...

    SBIR Phase II 1987 Environmental Protection Agency

  2. ZONE I SOIL DECONTAMINATION THROUGH IN SITU VAPOR STRIPPING PROCESSES

    SBC: Aware, Inc.            Topic: N/A

    N/A

    SBIR Phase I 1986 Environmental Protection Agency

  3. Z and Me, Science Solvers

    SBC: Optional Analysis            Topic: N/A

    N/A

    SBIR Phase I 1998 Department of Education

  4. Wound Healing Properties of a Non-Irritating Novel 9-cis Retinoid Acid Derivative

    SBC: MOLECULAR DESIGN INTERNATIONAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): MDI 301 is a synthetic retinoid that is similar to all-trans retinoic acid (RA) in its ability to stimulate collagen synthesis and inhibit the major collagen-degrading enzymes in skin. A major feature that distinguishes MDI 301 from RA is its lack of irritation when applied topically to skin. Recent studies from our laboratory have shown that topical treatment ...

    SBIR Phase I 2006 Department of Health and Human ServicesNational Institutes of Health

  5. Wound Healing Properties of a Non-Irritating Novel 9-cis Retinoid Acid Derivative

    SBC: MOLECULAR DESIGN INTERNATIONAL, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): MDI 301 is a synthetic retinoid that is similar to all-trans retinoic acid (RA) in its ability to stimulate collagen synthesis and inhibit the major collagen-degrading enzymes in skin. A feature that distinguishes MDI 301 from RA is its lack of irritation when applied topically to skin. Past studies from our laboratory have shown that topical pretreatment of ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health

  6. Wheelchair Drive System

    SBC: MAX MOBILITY            Topic: NICHD

    DESCRIPTION (provided by applicant): Wheelchair Drive System Over half of the wheelchair user population has developed upper extremity (UE) pain and injury. One of the activities that likely contribute to the development of injury is wheelchair propulsion. A number of technologies have been developed to address this issue including ergonomic pushrims, geared hub wheels, lever drives and pushrim-a ...

    SBIR Phase II 2011 Department of Health and Human ServicesNational Institutes of Health

  7. Web-based Training of Peers to Deliver Diabetes Self-Management Support (DSMS)

    SBC: InquisitHealth, Inc.            Topic: NIMHD

    DESCRIPTION provided by applicant The Specific Aim of this proposal is to test the feasibility of developing utilizing and evaluating a web based diabetes self management support DSMS training program that is culturally tailored for the African American community Effective self management is the key to improving diabetes outcomes avoiding complications and reducing costs Ongoing mainte ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health

  8. Wearable Monitor for Recording the Activity of Brown Adipose Tissue

    SBC: MMTC, INC.            Topic: NIDDK

    DESCRIPTION (provided by applicant): Brown Adipose Tissues (BAT) are tissues that when activated become metabolically active and take calories from normal white fat and burn them. Safe methods for creating and activating (BAT) would therefore be of great value in fighting obesity, a leading preventable cause of death with increasing prevalence in adults and children and one of the most serious pub ...

    SBIR Phase I 2014 Department of Health and Human ServicesNational Institutes of Health

  9. Vulnerable Plaque Amplified Optical Analyzer

    SBC: Energy Research Company            Topic: NHLBI

    DESCRIPTION provided by applicant Energy Research Company ERCo in a collaboration with The City College of New York CCNY and Columbia University Medical Center CUMC proposes developing the Vulnerable Plaque Amplified Optical Analyzer VPAOA a fiber optic catheter instrument based on patented amplified spectroscopy technology for detecting and analyzing vulnerable plaque VP in corona ...

    STTR Phase I 2015 Department of Health and Human ServicesNational Institutes of Health

  10. VOLATILE MARKERS OF PULMONARY TUBERCULOSIS IN THE BREATH

    SBC: MENSSANA RESEARCH INC            Topic: N/A

    DESCRIPTION (provided by applicant): Background: Pulmonary tuberculosis (TB) is a growing public health problem, and detection is often costly and time-consuming. A breath test for volatile markers of Mycobacteria could provide a new test for the disease. An advanced new breath test routinely detects volatile organic compounds (VOCs) in breath in picomolar (10-12 mol/l) concentrations. M. tubercul ...

    SBIR Phase I 2002 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government